Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2022
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignanciesNorihiro Watanabe, Feiyan Mo, Rong Zheng, et al.Urology|October 30, 2016
Urologic Outcomes of Children With Hemorrhagic Cystitis After Bone Marrow Transplant at a Single InstitutionJason K Au, Christopher Graziano, Rodolfo A Elizondo, et al.Transplantation and Cellular Therapy|February 22, 2024
Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic MalignancyRebecca Epperly, Ying Li, Subodh Selukar, et al.Cytotherapy|June 18, 2023
Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysisAlexandre G Troullioud Lucas, Caroline A Lindemans, Senthil Velan Bhoopalan, et al.Journal for Immunotherapy of Cancer|March 4, 2015
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational applicationJiali Sun, Leslie E Huye, Natalia Lapteva, et al.Blood|December 25, 2023
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomasLaQuisa C Hill, Rayne H Rouce, Mengfen J Wu, et al.American Journal of Medical Genetics. Part A|January 15, 2019
Refining the Primrose syndrome phenotype: A study of five patients with ZBTB20 de novo variants and a review of the literatureRuth Cleaver, Jonathan Berg, Emily Craft, et al.The Journal of Clinical Investigation|July 19, 2016
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.Blood Advances|September 5, 2019
"Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipientsIfigeneia Tzannou, Ayumi Watanabe, Swati Naik, et al.Pediatric Blood & Cancer|June 20, 2023
Outcomes following intolerance to calcineurin inhibitor-based graft-versus-host disease prophylaxis in children after allogeneic hematopoietic cell transplantationDiana Wu, Ying Li, Yu Bi, et al.Pageof 12